Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories
RESHAPE, NCT05480046: Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Recruiting
N/A
1200
Europe
Risperidone ISM, OKEDI®
Rovi Pharmaceuticals Laboratories
Schizophrenia
06/24
06/24

Download Options